Employees walk along a path at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India (Photographer: Dhiraj Singh/Bloomberg)

BQEdge | Why Lupin Has A Bitter Pill To Swallow

BQEdge is specially curated for BQBlue subscribers. Every day this note will offer special equity market and stock-specific insights and flag select emerging trends in the tricky-to-trade derivatives market.

On Today's Edition

  • What do leading indicators suggest for Lupin's stock?

Watch | Pain Points For Lupin Stock